91 related articles for article (PubMed ID: 8331249)
1. [Ocular complications of intracarotid chemotherapies with nitrosourea agents].
Rigal-Sastourne JC; Bidaux F; Mir F; Crepy P; Lucas B; Renard JP; Derosier C; Maurin JF; Bourgeois H
J Fr Ophtalmol; 1993; 16(5):304-10. PubMed ID: 8331249
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of brain tumor with phenobarbital and continuous infusion of ACNU into internal carotid artery].
Yumitori K; Yamashita J; Teraura T; Handa H
No Shinkei Geka; 1983 Feb; 11(2):165-71. PubMed ID: 6573575
[No Abstract] [Full Text] [Related]
3. Ocular complication of combined intracarotid chemotherapy and osmotic blood-brain barrier disruption.
Suda K; Nakasu S; Saito A
Nihon Geka Hokan; 1985 Sep; 54(5):359-63. PubMed ID: 3938210
[No Abstract] [Full Text] [Related]
4. Phase I study of intracarotid PCNU.
Stewart DJ; Grahovac Z; Russel NA; Hugenholtz H; Gupta S; Benoit BC; Richard MT; Maroun JA; Hopkins HS; Locke L
J Neurooncol; 1987; 5(3):245-50. PubMed ID: 3681387
[TBL] [Abstract][Full Text] [Related]
5. Opening blood-brain-barrier by intracarotid infusion of papaverine in treatment of malignant cerebral glioma.
Xue H; Wang H; Kong L; Zhou H
Chin Med J (Engl); 1998 Aug; 111(8):751-3. PubMed ID: 11245034
[TBL] [Abstract][Full Text] [Related]
6. Hepatic arterial Fotemustine chemotherapy in patients with liver metastases from cutaneous melanoma is as effective as in ocular melanoma.
Siegel R; Hauschild A; Kettelhack C; Kähler KC; Bembenek A; Schlag PM
Eur J Surg Oncol; 2007 Jun; 33(5):627-32. PubMed ID: 17196362
[TBL] [Abstract][Full Text] [Related]
7. Optic nerve degeneration caused by supraophthalmic carotid artery infusion with cisplatin and ACNU. Case report.
Shimamura Y; Chikama M; Tanimoto T; Kawakami Y; Tsutsumi A
J Neurosurg; 1990 Feb; 72(2):285-8. PubMed ID: 2295924
[TBL] [Abstract][Full Text] [Related]
8. Prevention of ocular toxicity of carmustine (BCNU) with supraophthalmic intracarotid infusion.
Chrousos GA; Oldfield EH; Doppman JL; Cogan DG
Ophthalmology; 1986 Nov; 93(11):1471-5. PubMed ID: 3808609
[TBL] [Abstract][Full Text] [Related]
9. Severe ocular and orbital toxicity after intracarotid etoposide phosphate and carboplatin therapy.
Lauer AK; Wobig JL; Shults WT; Neuwelt EA; Wilson MW
Am J Ophthalmol; 1999 Feb; 127(2):230-3. PubMed ID: 10030580
[TBL] [Abstract][Full Text] [Related]
10. Intracarotid infusion of PCNU (NSC: 95466): preclinical toxicological study in dogs.
Goumnerova L; Richard MT; Addison D; Montpetit V; Stewart DJ
J Neurooncol; 1987; 5(3):205-9. PubMed ID: 3681384
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant intra-arterial hepatic fotemustine for high-risk uveal melanoma patients.
Voelter V; Schalenbourg A; Pampallona S; Peters S; Halkic N; Denys A; Goitein G; Zografos L; Leyvraz S
Melanoma Res; 2008 Jun; 18(3):220-4. PubMed ID: 18477897
[TBL] [Abstract][Full Text] [Related]
12. Treatment of malignant recurrent glioma by intra-arterial, infra-ophthalmic infusion of HECNU 1-(2-chloroethyl)-1-nitroso-3-(2-hydroxyethyl) urea. A phase II study.
Poisson M; Chiras J; Fauchon F; Debussche C; Delattre JY
J Neurooncol; 1990 Jun; 8(3):255-62. PubMed ID: 2193122
[TBL] [Abstract][Full Text] [Related]
13. Supraclinoid intracarotid chemotherapy using a flow-directed soft-tipped catheter.
Charnsangavej C; Lee Y; Carrasco CH; Feun LG; Tang RA; Wright K; Wallace S; Gianturco C
Radiology; 1985 Jun; 155(3):655-7. PubMed ID: 4001366
[TBL] [Abstract][Full Text] [Related]
14. [A safe and simple method of percutaneous transfemoral implantation of a port-catheter access system for hepatic artery chemotherapy infusion].
Kuroiwa T; Honda H; Yoshimitsu K; Irie H; Aibe H; Shinozaki K; Nishie A; Nakayama T; Masuda K
Gan To Kagaku Ryoho; 2001 Oct; 28(11):1573-7. PubMed ID: 11707983
[TBL] [Abstract][Full Text] [Related]
15. Ocular toxicity during adjuvant chemoendocrine therapy for early breast cancer: results from International Breast Cancer Study Group trials.
Gianni L; Panzini I; Li S; Gelber RD; Collins J; Holmberg SB; Crivellari D; Castiglione-Gertsch M; Goldhirsch A; Coates AS; Ravaioli A;
Cancer; 2006 Feb; 106(3):505-13. PubMed ID: 16369994
[TBL] [Abstract][Full Text] [Related]
16. Ocular and orbital complications of intraarterial cisplatin. A case report.
Wu HM; Lee AG; Lehane DE; Chi TL; Lewis RA
J Neuroophthalmol; 1997 Sep; 17(3):195-8. PubMed ID: 9304534
[TBL] [Abstract][Full Text] [Related]
17. Supraophthalmic carotid infusion for brain chemotherapy. Experience with a new single-lumen catheter and maneuverable tip.
Kapp JP; Parker JL; Tucker EM
J Neurosurg; 1985 Jun; 62(6):823-5. PubMed ID: 4039751
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of intra-arterial infusion chemotherapy for head and neck cancers using coaxial catheter technique: initial experience.
Tsurumaru D; Kuroiwa T; Yabuuchi H; Hirata H; Higaki Y; Tomita K
Cardiovasc Intervent Radiol; 2007; 30(2):207-11. PubMed ID: 17216381
[TBL] [Abstract][Full Text] [Related]
19. Supraophthalmic carotid infusion for brain-tumor chemotherapy. Technical note.
Kapp JP; Ross RL; Tucker EM
J Neurosurg; 1983 Apr; 58(4):616-8. PubMed ID: 6827360
[TBL] [Abstract][Full Text] [Related]
20. Ocular and orbital toxicity after intracarotid cisplatin therapy.
Margo CE; Murtagh FR
Am J Ophthalmol; 1993 Oct; 116(4):508-9. PubMed ID: 8213988
[No Abstract] [Full Text] [Related]
[Next] [New Search]
